170495 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
Methods and Compositions For Targeting Retinoic Acid For Solid Tumor Immunotherapy
#2SYNTHETIC RETINOIDS FOR USE IN RAR ACTIVATION
#3FATTY ACID MIMETICS AS MODULATORS OF NUCLEAR RECEPTOR TLX (NR2E1)
#4Cardiovascular Disease
#5MONOCLONAL ANTIBODIES SPECIFIC FOR HUMAN ROR1
#6RXR-ALPHA BINDERS AND RXR-ALPHA/PLK1 MODULATORS
#7ENHANCED MITOCHONDRIAL RESPONSE WITH THIOZOLIDINEDIONE, PIOGLITAZONE OR ROSIGLITAZONE
#8METHODS OF PREVENTING OR TREATING PARKINSON'S DISEASE BY THE FARNESYLATION OF PARIS
#9SYNTHETIC RETINOIDS FOR USE IN RAR ACTIVATION
#10Methods And Compositions For Targeting Retinoic Acid For Solid Tumor Immunotherapy
#11Compositions and methods for treatment of peroxisome proliferator-activated receptor gamma (PPARG) activated cancer
#12AhR-ROR-γt complex as a biomarker and therapeutic target for autoimmune disease and IL-17A-associated disease
#13METHODS AND SYSTEMS FOR SCREENING CANDIDATE COMPOUNDS FOR THEIR POTENTIAL TO CAUSE SYSTEMIC OR HEPATIC TOXICITY
#14Multiplex MRM assay for evaluation of cancer
#15EXPANSION OF RENEWABLE STEM CELL POPULATIONS
#16Pharmaceutical compositions for preventing or treating inflammatory bowel diseases
#17Methods and compositions related to retinoid receptor-selective pathway
#18Kit for rapidly testing myocardial infarction and a preparation method and an application thereof
#19Systems and methods for the monitoring of protein complex formation in cells
#20Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof
#21METHODS FOR DETERMINING RELATIVE BINDING ENERGY OF MONOMERS AND METHODS OF USING THE SAME
#22Multiplex MRM assay for evaluation of cancer
#23Methods for suppressing adipocyte differentiation
#24METHOD AND COMPOSITIONS FOR DETECTING BINDING TO THE PREGNANE X RECEPTOR
#25Methods of screening compounds that can modulate NR2F6 by displacement of a reference ligand
#26METHODS FOR DETERMINING RELATIVE BINDING ENERGY OF MONOMERS AND METHODS OF USING THE SAME
#27PGC-1beta-protein-function regulator, mitochondria-function regulator, anti-obesity agent, and screening method therefor
#28Selective androgen receptor modulators
#29Methods and compositions related to a retinoid receptor-selective pathway
#30LANTHIONINE SYNTHETASE COMPONENT C-LIKE PROTEINS AS MOLECULAR TARGETS FOR PREVENTING AND TREATING DISEASES AND DISORDERS
#31MEANS AND METHODS FOR TREATING OR PREVENTING BRAIN TUMORS BASED ON THE NUCLEAR RECEPTOR TAILLESS (TIX)
#32Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof
#33CANCER PROGNOSTIC ASSAYS
#34Curaxins for use in treating carcinogen-induced cancer
#35Methods and composition for measuring the amount of vitamin D derivatives
#36Modulation of NR2F6 and methods and uses thereof
#37Compositions, kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders
#38Omega-3 fatty acid nutriceutical composition and optimization method
#39Methods of treating lupus
#40Methods and composition for measuring the amount of Vitamin D derivatives
#41ROR ALPHA PROMOTING THE INDUCTION OF BMALL
#42Lanthionine synthetase component C-like proteins as molecular targets for preventing and treating diseases and disorders
#43Methods of identification of novel ligands for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (NR1F3) activity
#44IN VITRO METHOD TO DETERMINE WHETHER A DRUG CANDIDATE ACTIVE AGAINST A TARGET PROTEIN IS ACTIVE AGAINST A VARIANT OF SAID PROTEIN
#45SIRT1 Modulation of Adipogenesis and Adipose Function
#46Methods for Screening Compounds for Treating and/or Preventing an Hepatitis C Virus Infection
#47NOVEL THERAPEUTIC TARGETS IN INFLAMMATORY BOWEL DISEASE
#48Means and methods for treating or preventing brain tumors based on the nuclear receptor tailless (Tlx)
#49Expansion Of Renewable Stem Cell Populations
#50Methods and compositions related to TR4 ligand
#51Compositions and methods for inhibiting adipogenesis by inhibition of constitutive coactivator of ppargamma
#52HNF4alpha MODULATORS AND METHODS OF USE
#53NEUROPROTECTION AND PREVENTION OF DOPAMINERGIC CELL DEATH BY TARGETING NUR77 TRANSLOCATION
#54AUTO-ANTIBODY MARKERS OF AUTOIMMUNE DISEASE
#55Use of an endogenous ligand for peroxisome proliferator activated receptor alpha to treat liver disorders
#56Method for the assay of liver fatty acid binding protein, ACE and CA 19-9 for the in vitro diagnosis of colorectal cancer
#57Modulation of NR2F6 and methods and uses thereof
#58Inhibition of PPAR gamma expression by specific osteogenic oxysterols
#59NOTCH mutations leading to increased receptor signaling
#60ROR-alpha Promoting the Induction of Bmall
#61METHODS FOR IDENTIFYING NUCLEAR RECEPTOR/LIGAND COMBINATIONS FOR TARGETING BRAIN TUMOR STEM CELLS AND FOR THEIR USE
#62Nuclear receptor assay
#63CRAB-PII DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE
#64RORS as modifiers of the p21 pathway and methods of use
#65Method for Testing Substances or Mixtures of Substances,Use of Said Method and Corresponding Test Kits
#66Functional genomic pore assay for mixed cell populations
#67Use of LXR agonists for the treatment of osteoarthritis
#68Identification of an evolutionarily conserved pathway mediating transrepression of inflammatory response genes by nuclear receptors
#69Polypeptide fragment of constitutive coactivator of PPARgamma
#70Therapy employing LXRalpha modolators
#71Method for identifying compounds that modulate RXR associated processes with IgE production
#72Diagnostics and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Delta (Ppard)
#73Nezara viridula Ecdysone Receptor
#74NOTCH mutations leading to increased receptor signaling
#75Neuregulin protein regulation of synaptic proteins
#76Ligands for orphan nuclear hormone receptor steroidogenic factor-1 (SF-1)
#77Method of identifying a PPARgamma-agonist compound having a decreased likelihood of inducing dose-dependent peripheral edema
#78Method for modulating process mediated by farnesoid activated receptors
#79Induction of tumor cell senescence by retinoid receptor agonists and antagonists
#80Nuclear receptor err y 3
#81Cellular retinoic acid binding protein II as a marker for breast cancer
#82Computational knowledge model to discover molecular causes and treatment of diabetes mellitus
#83Rors as modifiers of the p21 pathway and methods of use
#84Tr4/tr2 response elements
#85Orphan receptor TLX and uses therefor
#86Methods and formulations comprising agonists and antagonists of nuclear hormone receptors
#87Method for the idenification of ligands
#88Methods for affecting various diseases utilizing LXR compounds
#89Methods of inducing differentiation in ex vivo expanded stem cells
#90Plant cells having receptor polypeptides
#91Method for screening a substance which can suppress degradation of a nuclear receptor or a substance which can promote degradation of a nuclear receptor
#92Novel modulator of non-genomic activity of nuclear receptors (mnar) and uses thereof
#93SIRT1 modulation of adipogenesis and adipose function
#94Methods of screening for compounds that modulate hormone receptor activity
#95Method for performing in vitro diagnosis using gene regulation mechanisms and corresponding diagnosis kit
#96Compositions and methods for altering glucose production
#97Compositions and methods for regulating thyroid hormone metabolism and cholesterol and lipid metabolism via the nuclear receptor car
#98Methods for determining whether an agent possesses a defined biological activity
#99Method for screening drug for improving insulin resistance
#100Expansion of renewable stem cell populations using modulators of PI 3-kinase
#101EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
#102Cytoplasmic activity of retinoid X receptor and its regulation by ligands and dimerization
#103Expansion of renewable stem cell populations
#104Omega-3 fatty acid nutriceutical compositions and methods